Cancer Research Annual Meeting 2010  EMT and Cancer Progression and Treatment
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Kundranda, M. N.
Right arrow Articles by Ochieng, J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Kundranda, M. N.
Right arrow Articles by Ochieng, J.
[Cancer Research 65, 499-506, January 15, 2005]
© 2005 American Association for Cancer Research


Cell and Tumor Biology

The Serum Glycoprotein Fetuin-A Promotes Lewis Lung Carcinoma Tumorigenesis via Adhesive-Dependent and Adhesive-Independent Mechanisms

Madappa N. Kundranda1, Melodie Henderson3, Kathy J. Carter3, Lee Gorden3, Awadh Binhazim2, Sanhita Ray1, Trevor Baptiste1, Masih Shokrani1, Maria L. Leite-Browning3, Willi Jahnen-Dechent4, Lynn M. Matrisian3 and Josiah Ochieng1,3

Departments of 1 Biochemistry and 2 Pathology, Meharry Medical College and 3 Department of Cancer Biology, Vanderbilt University, Nashville, Tennessee, and 4 IZKF BIOMAT, University Clinics, Aachen, Germany

Requests for reprints: Josiah Ochieng, Meharry Medical College, Nashville, TN 37208. Phone: 615-327-6119; Fax: 615-327-6442; E-mail: jochieng{at}mmc.edu.

Fetuin-A is a serum glycoprotein in the cystatin family associated with the regulation of soft tissue calcification. We tested the role of systemic fetuin in tumor cell growth and metastasis by injecting Lewis lung carcinoma (LLC) cells into fetuin-A null and their wild-type (WT) littermate control C57BL/6 mice via the tail vein, s.c., and intrasplenic routes. In the experimental metastasis assay, the lungs of the WT mice were filled with metastatic nodules, whereas the lungs of the fetuin-A null mutant mice were virtually free of colonies at the end of 2 weeks. Lung colonization responded to the levels of serum fetuin-A in a dose-dependent manner, as observed by the formation of half as many colonies in mice heterozygous for the fetuin-A locus compared with homozygous WT mice and restoration of lung colonization by the administration of purified fetuin-A to fetuin-A-null mice. Serum fetuin-A also influenced the growth of LLC cells injected s.c.: fetuin-A-null mice developed small s.c. tumors only after a substantial delay. Similarly, intrasplenic injection of LLC cells resulted in rapid colonization of the liver with metastasis to the lungs within 2 weeks in the WT but not fetuin-A null mice. To examine the mechanism by which fetuin-A influences LLC colonization and growth, we showed that LLC tumor cells adhere to fetuin-A in a Ca2+-dependent fashion, resulting in growth of the tumor cells. These studies support the role of fetuin-A as a major growth promoter in serum that can influence tumor establishment and growth.

Key Words: Tumor promotion and progression • CELLULAR, MOLECULAR, AND TUMOR BIOLOGY • Tumor-stromal cell interactions • Tumor Progression, Invasion, and Metastasis • Cell Growth/ Signaling Pathways




This article has been cited by other articles:


Home page
Mol. Cell. ProteomicsHome page
P. M. Karamessinis, A. Malamitsi-Puchner, T. Boutsikou, M. Makridakis, K. Vougas, M. Fountoulakis, A. Vlahou, and G. Chrousos
Marked Defects in the Expression and Glycosylation of {alpha}2-HS Glycoprotein/Fetuin-A in Plasma from Neonates with Intrauterine Growth Restriction: Proteomics Screening and Potential Clinical Implications
Mol. Cell. Proteomics, March 1, 2008; 7(3): 591 - 599.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 2005 by the American Association for Cancer Research.